The University of Chicago Header Logo

Connection

Dejan Micic to Middle Aged

This is a "connection" page, showing publications Dejan Micic has written about Middle Aged.
Connection Strength

2.225
  1. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Nutr Clin Pract. 2024 Jun; 39(3):634-640.
    View in: PubMed
    Score: 0.244
  2. Predictive Model for Positive Video Capsule Endoscopy in Iron Deficiency Anemia. Dig Dis Sci. 2023 07; 68(7):3083-3091.
    View in: PubMed
    Score: 0.227
  3. Impact of Early Video Capsule Endoscopy on Hospitalization and Post-hospitalization Outcomes: A Propensity Score-Matching Analysis. Dig Dis Sci. 2022 08; 67(8):3584-3591.
    View in: PubMed
    Score: 0.204
  4. Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849.
    View in: PubMed
    Score: 0.187
  5. Getting to the Root of the Problem. Gastroenterology. 2020 04; 158(5):1229-1231.
    View in: PubMed
    Score: 0.179
  6. Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy. PLoS One. 2019; 14(2):e0212509.
    View in: PubMed
    Score: 0.172
  7. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024.
    View in: PubMed
    Score: 0.160
  8. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900.
    View in: PubMed
    Score: 0.155
  9. Factors associated with long-term clinical outcome in microscopic colitis. Ann Med. 2024 Dec; 56(1):2365989.
    View in: PubMed
    Score: 0.062
  10. Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer. J Clin Gastroenterol. 2023 09 01; 57(8):804-809.
    View in: PubMed
    Score: 0.059
  11. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
    View in: PubMed
    Score: 0.044
  12. Risk Factors for 30-day Hospital Readmission for Diverticular Hemorrhage. J Clin Gastroenterol. 2019 04; 53(4):e133-e141.
    View in: PubMed
    Score: 0.043
  13. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 06; 19(6):758-767.
    View in: PubMed
    Score: 0.041
  14. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
    View in: PubMed
    Score: 0.040
  15. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.040
  16. Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
    View in: PubMed
    Score: 0.039
  17. Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
    View in: PubMed
    Score: 0.039
  18. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
    View in: PubMed
    Score: 0.035
  19. Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3.
    View in: PubMed
    Score: 0.033
  20. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15; 61(2):233-41.
    View in: PubMed
    Score: 0.033
  21. Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7.
    View in: PubMed
    Score: 0.032
  22. In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
    View in: PubMed
    Score: 0.031
  23. The systemic inflammatory response to Clostridium difficile infection. PLoS One. 2014; 9(3):e92578.
    View in: PubMed
    Score: 0.030
  24. Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014; 9(2):e89332.
    View in: PubMed
    Score: 0.030
  25. Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One. 2013; 8(3):e58265.
    View in: PubMed
    Score: 0.028
  26. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012 Dec; 55(12):1661-8.
    View in: PubMed
    Score: 0.027
  27. [Diverticulosis of the digestive tract in our patients over a 10-year period]. Zb Vojnomed Akad. 1981; 23:42-5.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.